# TARA (Protara Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Protara Therapeutics, Inc. reported $156.5M in total assets and a net loss of $78.44M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/TARA
- Markdown: https://convexityos.com/fundamentals/TARA.md
- SEC CIK: 0001359931
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:47 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001359931&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$85.19M | Operating profit |
| Net Income | FY 2025 | -$78.44M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.25 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$56.46M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $127.0M | Total debt: $2.44M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $42.63M | $31.70M | $24.99M | $16.81M | $21.09M | $11.98M | $3.88M | $11.85M | $21.69M | $18.87M |
| Total Operating Expenses | $64.55M | $49.15M | $43.61M | $67.06M | $47.49M | $34.44M | $7.83M | $21.37M | $30.36M | $28.70M |
| **Operating Income** | -$64.55M | -$49.15M | -$43.61M | -$67.06M | -$47.49M | -$34.44M | -$7.83M | -$21.37M | -$30.36M | -$28.70M |
| **EBITDA** | -$64.19M | -$48.82M | -$43.27M | -$66.81M | -$47.37M | -$34.34M | -$7.81M | -$21.26M | -$30.21M | -$28.58M |
| Interest Income | $6.38M | $4.17M | $3.19M | $1.11M | $237K | $500K | -- | -- | -- | -- |
| Interest Expense | -- | -- | -- | -- | $0 | $34K | -- | -- | -- | -- |
| Income Before Tax | $57.35M | $44.56M | -- | -- | -- | -- | -$14.99M | -$20.73M | -$29.96M | -$28.53M |
| **Net Income** | -$57.44M | -$44.60M | -$40.42M | -$65.95M | -$47.25M | -$33.98M | -$7.83M | -$20.73M | -$29.96M | -$28.53M |
| Basic EPS | -$1.34 | -$2.17 | -$3.57 | -$5.86 | -$4.21 | -$4.70 | -$3.04 | -$45.80 | -$2.13 | -$1.72 |
| **Diluted EPS** | -$1.34 | -$2.17 | -$3.57 | -$5.86 | -$4.21 | -$4.70 | -$3.04 | -$45.80 | -$2.13 | -$1.72 |
| Basic Shares Outstanding | 42.8M | 20.6M | 11.3M | 11.3M | 11.2M | 7.2M | 2.6M | 452.6K | 17.3M | 16.6M |
| Diluted Shares Outstanding | 42.8M | 20.6M | 11.3M | 11.3M | 11.2M | 7.2M | 2.6M | 452.6K | 17.3M | 16.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $16.80M | $16.95M | $13.56M | $13.12M | $9.59M | $10.77M | $9.15M | $9.50M |
| Total Operating Expenses | $23.15M | $23.32M | $19.63M | $19.08M | $14.76M | $16.59M | $14.12M | $14.31M |
| **Operating Income** | -$23.15M | -$23.32M | -$19.63M | -$19.08M | -$14.76M | -$16.59M | -$14.12M | -$14.31M |
| **EBITDA** | -$23.08M | -$23.25M | -$19.54M | -$18.99M | -$14.67M | -$16.49M | -$14.04M | -$14.23M |
| Interest Income | $1.47M | $1.66M | $1.85M | $1.52M | $1.50M | $1.63M | $1.73M | $1.16M |
| **Net Income** | -$21.69M | -$21.67M | -$17.78M | -$17.31M | -$13.26M | -$14.96M | -$11.91M | -$12.77M |
| Basic EPS | -$0.35 | -$0.36 | -$0.31 | -- | -$0.31 | -$0.35 | -$0.29 | -- |
| **Diluted EPS** | -$0.35 | -$0.36 | -$0.31 | -- | -$0.31 | -$0.35 | -$0.29 | -- |
| Basic Shares Outstanding | 62.9M | 61.0M | 57.5M | -- | 42.3M | 42.3M | 40.7M | -- |
| Diluted Shares Outstanding | 62.9M | 61.0M | 57.5M | -- | 42.3M | 42.3M | 40.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $49.66M | $162.8M | $39.59M | $24.13M | $35.72M | $168.6M | $564K | $19.37M | $21.17M | $36.39M |
| Short-Term Investments | $105.9M | $7.49M | $25.99M | $60.24M | $55.51M | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $155.6M | $170.3M | $65.58M | $84.37M | $91.23M | $168.6M | $6.20M | $21.90M | $42.10M | $41.30M |
| Other Current Assets | $65K | $2.0K | $37K | $127K | $34K | $52K | -- | -- | -- | -- |
| **Total Current Assets** | $159.5M | $172.2M | $68.70M | $86.15M | $93.11M | $169.4M | $764K | $23.24M | $43.48M | $42.76M |
| Property, Plant & Equipment, Net | $759K | $1.03M | $1.30M | $1.59M | $1.72M | $1.24M | $459K | $263K | $259K | $372K |
| Goodwill | -- | -- | -- | -- | $29.52M | $29.52M | -- | -- | -- | -- |
| Long-Term Investments | $42.34M | -- | -- | $17.89M | $39.47M | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $20K | $27K | $11K | $16K | $865K | $1.16M | -- | -- | $218K | $393K |
| **Total Non-Current Assets** | $49.96M | $9.30M | $10.25M | $27.14M | $79.48M | $33.72M | $459K | $285K | $499K | $765K |
| **Total Assets** | $209.5M | $181.5M | $78.95M | $113.3M | $172.6M | $203.2M | $1.22M | $23.52M | $43.98M | $43.52M |
| Accounts Payable | $3.47M | $4.43M | $2.43M | $1.59M | $954K | $914K | $716K | $441K | $291K | $556K |
| Short-Term Debt | -- | -- | -- | -- | $0 | $0 | -- | -- | -- | -- |
| **Total Current Liabilities** | $10.94M | $10.96M | $6.15M | $5.74M | $4.30M | $2.92M | $3.35M | $3.08M | $9.24M | $5.08M |
| **Total Non-Current Liabilities** | $2.12M | $3.36M | $4.48M | $5.47M | $6.38M | $999K | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $13.06M | $14.32M | $10.63M | $11.21M | $10.68M | $3.91M | $3.35M | $3.08M | $9.24M | $5.08M |
| **Total Debt (incl. Leases)** | $3.36M | $4.48M | $5.47M | $6.38M | $7.24M | $1.15M | -- | -- | -- | -- |
| Common Stock | $54K | $35K | $11K | $11K | $11K | $11K | $3.0K | $19K | $18K | $17K |
| Retained Earnings | -$302.4M | -$245.0M | -$200.4M | -$160.0M | -$94.01M | -$46.76M | -$12.78M | -$210.5M | -$189.7M | -$159.8M |
| Accumulated Other Comp. Income | $90K | $2.0K | -$31K | -$688K | -$211K | -- | $3.0K | $5.0K | -$14K | -- |
| **Total Stockholders' Equity** | $196.4M | $167.1M | $68.32M | $102.1M | $161.9M | $199.2M | -$2.13M | $4.78M | $34.74M | $38.44M |
| Total Equity | $196.4M | $167.1M | $68.32M | $102.1M | $161.9M | $199.2M | -$2.13M | $4.78M | $34.74M | $38.44M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $25.15M | $17.08M | $14.74M | $49.66M | $12.55M | $31.50M | $91.46M | $162.8M |
| Short-Term Investments | $101.9M | $125.4M | $121.0M | $105.9M | $120.1M | $90.72M | $32.90M | $7.49M |
| **Cash & Short-Term Investments** | $127.0M | $142.5M | $135.8M | $155.6M | $132.7M | $122.2M | $124.4M | $170.3M |
| Other Current Assets | $19K | $230K | $17K | $65K | $218K | $78K | $16K | $2.0K |
| **Total Current Assets** | $129.7M | $146.2M | $140.0M | $159.5M | $135.6M | $125.1M | $126.5M | $172.2M |
| Property, Plant & Equipment, Net | $1.58M | $1.32M | $669K | $759K | $828K | $912K | $988K | $1.03M |
| Long-Term Investments | $16.03M | $19.36M | $41.64M | $42.34M | $957K | $23.39M | $33.15M | -- |
| Other Non-Current Assets | $60K | $74K | $76K | $20K | $21K | $29K | $35K | $27K |
| **Total Non-Current Assets** | $26.87M | $29.94M | $51.93M | $49.96M | $8.99M | $31.84M | $42.03M | $9.30M |
| **Total Assets** | $156.5M | $176.1M | $191.9M | $209.5M | $144.6M | $156.9M | $168.6M | $181.5M |
| Accounts Payable | $4.86M | $4.66M | $4.03M | $3.47M | $4.50M | $5.30M | $2.31M | $4.43M |
| **Total Current Liabilities** | $14.39M | $13.32M | $8.92M | $10.94M | $9.91M | $9.76M | $7.02M | $10.96M |
| **Total Non-Current Liabilities** | $1.13M | $1.46M | $1.79M | $2.12M | $2.44M | $2.75M | $3.06M | $3.36M |
| **Total Liabilities** | $15.52M | $14.78M | $10.71M | $13.06M | $12.35M | $12.51M | $10.07M | $14.32M |
| **Total Debt (incl. Leases)** | $2.44M | $2.75M | $3.06M | $3.36M | $3.66M | $3.95M | $4.23M | $4.48M |
| Common Stock | $60K | $59K | $55K | $54K | $39K | $39K | $39K | $35K |
| Retained Earnings | -$363.6M | -$341.9M | -$320.2M | -$302.4M | -$285.1M | -$271.9M | -$256.9M | -$245.0M |
| Accumulated Other Comp. Income | -$550K | -$363K | -$364K | $90K | $143K | $77K | $89K | $2.0K |
| **Total Stockholders' Equity** | $141.0M | $161.3M | $181.2M | $196.4M | $132.3M | $144.4M | $158.5M | $167.1M |
| Total Equity | $141.0M | $161.3M | $181.2M | $196.4M | $132.3M | $144.4M | $158.5M | $167.1M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$57.44M | -$44.60M | -$40.42M | -$65.95M | -$47.25M | -$33.98M | -$7.83M | -$20.73M | -$29.96M | -$28.53M |
| Depreciation & Amortization | $362K | $332K | $341K | $248K | $117K | $103K | $16K | $115K | $148K | $123K |
| Stock-Based Compensation | $3.83M | $4.12M | $6.09M | $6.69M | $10.36M | $9.75M | $424K | $3.43M | $3.23M | $3.34M |
| Change in Payables | -$873K | $1.38M | $848K | $631K | $40K | $198K | $366K | -- | -- | -- |
| **Operating Cash Flow** | -$56.37M | -$35.81M | -$37.56M | -$26.46M | -$34.50M | -$23.41M | -$5.01M | -$23.23M | -$22.35M | -$23.69M |
| Capital Expenditure | -$94K | -$63K | -$45K | -$120K | -$596K | -$884K | -$475K | -$119K | -$35K | -$271K |
| **Free Cash Flow** | -$56.46M | -$35.87M | -$37.60M | -$26.58M | -$35.10M | -$24.29M | -$5.49M | -$23.35M | -$22.39M | -$23.96M |
| Acquisitions, Net | -- | -- | -- | -- | -- | $3.72M | -- | -- | -- | -- |
| Purchases of Investments | -$204.6M | -$29.38M | -$12.19M | -$43.55M | -$124.7M | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$139.5M | $19.16M | $53.11M | $14.95M | -$98.19M | $2.83M | -$475K | $18.43M | -$16.10M | $19.92M |
| Common Stock Issued | -- | -- | -- | -- | -- | $73.57M | -- | -- | -- | -- |
| Share Repurchases | -- | -- | -$91K | -$90K | -$228K | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $82.72M | $139.9M | -$91K | -$90K | -$228K | $189.4M | $500K | $2.98M | $23.05M | $208K |
| **Net Change in Cash** | -$113.1M | $123.2M | $15.46M | -$11.60M | -$132.9M | $168.8M | -$13.16M | -$1.80M | -$15.22M | -$3.64M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$21.69M | -$21.67M | -$17.78M | -$17.31M | -$13.26M | -$14.96M | -$11.91M | -$12.77M |
| Depreciation & Amortization | $71K | $72K | $90K | $93K | $88K | $98K | $83K | $82K |
| Stock-Based Compensation | $1.59M | $1.38M | $1.36M | $1.04M | $1.05M | $903K | $833K | $904K |
| Change in Payables | $588K | $243K | $1.09M | -$1.56M | -$795K | $2.99M | -$1.50M | $1.52M |
| **Operating Cash Flow** | -$18.44M | -$15.39M | -$21.34M | -$16.95M | -$12.45M | -$12.25M | -$14.71M | -$9.31M |
| Capital Expenditure | -- | -- | -- | -$24K | -$4.0K | -$22K | -$44K | -- |
| **Free Cash Flow** | -- | -- | -- | -$16.97M | -$12.46M | -$12.27M | -$14.76M | -- |
| Purchases of Investments | -$11.78M | -$19.23M | -$43.86M | -$62.71M | -$24.41M | -$51.70M | -$65.81M | -- |
| **Investing Cash Flow** | $26.10M | $17.75M | -$14.72M | -$26.91M | -$6.51M | -$47.72M | -$58.35M | $22.50M |
| **Financing Cash Flow** | $412K | -$26K | $1.14M | $80.96M | $13K | $8.0K | $1.73M | $97.85M |
| **Net Change in Cash** | $8.07M | $2.34M | -$34.92M | $37.11M | -$18.95M | -$59.97M | -$71.34M | $111.0M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -29.2% | -26.7% | -59.2% | -64.6% | -29.2% | -17.1% | -- | -433.8% | -86.3% | -74.2% |
| Return on Assets (ROA) | -27.4% | -24.6% | -51.2% | -58.2% | -27.4% | -16.7% | -640.2% | -88.1% | -68.1% | -65.5% |
| Current Ratio | 14.58x | 15.71x | 11.17x | 15.01x | 21.66x | 58.13x | 0.23x | 7.55x | 4.71x | 8.42x |
| Quick Ratio | 14.22x | 15.54x | 10.67x | 14.70x | 21.23x | 57.84x | 1.85x | 7.12x | 4.56x | 8.13x |
| Debt to Equity | 0.02x | 0.03x | 0.08x | 0.06x | 0.04x | 0.01x | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -55.6% | -43.4% | -34.9% | -29.2% | -40.0% | -35.2% | -28.7% | -26.7% |
| Return on Assets (ROA) | -50.1% | -39.8% | -33.0% | -27.4% | -36.6% | -32.4% | -26.9% | -24.6% |
| Current Ratio | 9.01x | 10.97x | 15.69x | 14.58x | 13.69x | 12.82x | 18.03x | 15.71x |
| Quick Ratio | 8.83x | 10.70x | 15.22x | 14.22x | 13.39x | 12.52x | 17.72x | 15.54x |
| Debt to Equity | 0.02x | 0.02x | 0.02x | 0.02x | 0.03x | 0.03x | 0.03x | 0.03x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
